Deborah H. Telman - 25 Apr 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: EVP, Corporate Affairs & GC
Signature: /s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol: GILD
Transactions as of: 25 Apr 2025
Net transactions value: -$16,301
Form type: 4
Filing time: 28 Apr 2025, 13:24:48 UTC
Previous filing: 12 Mar 2025
Next filing: 21 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+514	+1.4%		37,076	25 Apr 2025	Direct	F1
transaction	GILD	Common Stock	Tax liability	$16,301	-158	-0.43%	$103.17	36,918	25 Apr 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-514	-1.6%		31,702	25 Apr 2025	Common Stock	514		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.